id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02425904
27:39:treatment,43:55:treatment,,84:96:treatment,100:111:treatment,247:271:treatment
Participants who have had chemotherapy or radiotherapy within 2 weeks (6 weeks for nitrosoureas or mitomycin C) prior to entering the study or those who have not recovered from adverse events due to agents administered more than 2 weeks earlier. Corticosteroid treatment is allowed
1
[ "Participants", "who", "have", "had", "chemotherapy", "or", "radiotherapy", "within", "2", "weeks", "(", "6", "weeks", "for", "nitrosoureas", "or", "mitomycin", "C", ")", "prior", "to", "entering", "the", "study", "or", "those", "who", "have", "not", "recovered", "from", "adverse", "events", "due", "to", "agents", "administered", "more", "than", "2", "weeks", "earlier", ".", "Corticosteroid", "treatment", "is", "allowed" ]
[ 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0 ]
NCT02092324
32:61:allergy_name
Previous allergic reactions to janus kinase (JAK) inhibitors or excipients
1
[ "Previous", "allergic", "reactions", "to", "janus", "kinase", "(", "JAK", ")", "inhibitors", "or", "excipients" ]
[ 0, 0, 0, 0, 4, 4, 4, 4, 0, 0, 0, 0 ]
NCT01415882
20:40:treatment,58:68:treatment,73:84:treatment,,125:132:treatment,,
Patients should be proteasome inhibitor naïve (including bortezomib and carfilzomib) OR have received less than 6 cycles of therapy with a bortezomib or carfilzomib containing regimen and were not refractory to the bortezomib or carfilzomib based regimen (less than a PR or progression on or within 60 days of discontinuation)
1
[ "Patients", "should", "be", "proteasome", "inhibitor", "naïve", "(", "including", "bortezomib", "and", "carfilzomib", ")", "OR", "have", "received", "less", "than", "6", "cycles", "of", "therapy", "with", "a", "bortezomib", "or", "carfilzomib", "containing", "regimen", "and", "were", "not", "refractory", "to", "the", "bortezomib", "or", "carfilzomib", "based", "regimen", "(", "less", "than", "a", "PR", "or", "progression", "on", "or", "within", "60", "days", "of", "discontinuation", ")" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01851694
13:28:treatment,
intravenous corticosteroids within 6 weeks of study
1
[ "intravenous", "corticosteroids", "within", "6", "weeks", "of", "study" ]
[ 0, 1, 0, 0, 0, 0, 0 ]
NCT02561988
1:17:cancer
Brain malignancy
1
[ "Brain", "malignancy" ]
[ 3, 3 ]
NCT01891318
1:9:cancer
lymphoma
1
[ "lymphoma" ]
[ 3 ]
NCT03065907
22:66:chronic_disease,
Primary diagnosis of neovascular age-related macular degeneration in the index eye or in both eyes if habitual visual acuity (HVA) is equivalent in both eyes
1
[ "Primary", "diagnosis", "of", "neovascular", "age-related", "macular", "degeneration", "in", "the", "index", "eye", "or", "in", "both", "eyes", "if", "habitual", "visual", "acuity", "(", "HVA", ")", "is", "equivalent", "in", "both", "eyes" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02496585
16:46:chronic_disease
Active chronic Hepatitis C and/or B infection
1
[ "Active", "chronic", "Hepatitis", "C", "and/or", "B", "infection" ]
[ 0, 0, 2, 2, 2, 2, 2 ]
NCT01760863
27:75:treatment,187:210:treatment,246:262:treatment
Adult patients undergoing 2-stage revision arthroplasty of the knee or hip with the causative organism(s) identified using tissue culture and/or joint fluid analysis that is amenable to oral antibiotic therapy. Patients must be able to tolerate oral antibiotics and agree to participate in the study
1
[ "Adult", "patients", "undergoing", "2-stage", "revision", "arthroplasty", "of", "the", "knee", "or", "hip", "with", "the", "causative", "organism", "(", "s", ")", "identified", "using", "tissue", "culture", "and/or", "joint", "fluid", "analysis", "that", "is", "amenable", "to", "oral", "antibiotic", "therapy", ".", "Patients", "must", "be", "able", "to", "tolerate", "oral", "antibiotics", "and", "agree", "to", "participate", "in", "the", "study" ]
[ 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02667418
,,,,74:92:treatment
Negative pregnancy test required for females <61 years of age or without prior hysterectomy
1
[ "Negative", "pregnancy", "test", "required", "for", "females", "<", "61", "years", "of", "age", "or", "without", "prior", "hysterectomy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02004275
4:25:treatment,
No platelet transfusions within 7 days of registration to meet eligibility criteria
1
[ "No", "platelet", "transfusions", "within", "7", "days", "of", "registration", "to", "meet", "eligibility", "criteria" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02471430
10:13:chronic_disease
negative HCV PCR if anti-HCV antibodies are positive
1
[ "negative", "HCV", "PCR", "if", "anti-HCV", "antibodies", "are", "positive" ]
[ 0, 2, 0, 0, 0, 0, 0, 0 ]
NCT01793519
43:58:treatment,
Treated with intramuscular or intravenous corticosteroids in the last 6 months for RA activity
1
[ "Treated", "with", "intramuscular", "or", "intravenous", "corticosteroids", "in", "the", "last", "6", "months", "for", "RA", "activity" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02301663
1:18:treatment
metallic implants
1
[ "metallic", "implants" ]
[ 1, 1 ]
NCT02908906
45:57:cancer
Participants enrolled into Part 2 must have tumor tissue available for correlative studies
1
[ "Participants", "enrolled", "into", "Part", "2", "must", "have", "tumor", "tissue", "available", "for", "correlative", "studies" ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0 ]
NCT02774421
1:13:cancer
mixed glioma
1
[ "mixed", "glioma" ]
[ 3, 3 ]
NCT02072148
1:4:chronic_disease,14:19:cancer,51:54:treatment
HPV negative OPSCC as determined by determined by PCR
1
[ "HPV", "negative", "OPSCC", "as", "determined", "by", "determined", "by", "PCR" ]
[ 2, 0, 3, 0, 0, 0, 0, 0, 1 ]
NCT02162420
1:21:cancer,,,,
Refractory cytopenia defined by bone marrow cellularity <50% (with < 30% residual hematopoietic cells)
1
[ "Refractory", "cytopenia", "defined", "by", "bone", "marrow", "cellularity", "<", "50", "%", "(", "with", "<", "30", "%", "residual", "hematopoietic", "cells", ")" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02430077
1:24:chronic_disease
Acute medical illnesses precluding participation in the studies
1
[ "Acute", "medical", "illnesses", "precluding", "participation", "in", "the", "studies" ]
[ 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT02385110
73:76:chronic_disease
The diagnostic criteria that have been traditionally used for children (HLH 1991 and HLH 2004) may not adequately diagnose HLH in adults
1
[ "The", "diagnostic", "criteria", "that", "have", "been", "traditionally", "used", "for", "children", "(", "HLH", "1991", "and", "HLH", "2004", ")", "may", "not", "adequately", "diagnose", "HLH", "in", "adults" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02495168
,,,,90:99:treatment,109:119:treatment,121:138:treatment
≥15% and ≥ 0.20 L reversibility of FEV1 within 30 minutes following 360 mcg (4 puffs) of albuterol (400 mcg salbutamol) inhalation (pMDI)
1
[ "≥15", "%", "and", "≥", "0.20", "L", "reversibility", "of", "FEV1", "within", "30", "minutes", "following", "360", "mcg", "(", "4", "puffs", ")", "of", "albuterol", "(", "400", "mcg", "salbutamol", ")", "inhalation", "(", "pMDI", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 1, 1, 0, 0 ]
NCT02674529
55:67:treatment
Have a history of inadequate response/tolerability to escitalopram
1
[ "Have", "a", "history", "of", "inadequate", "response/tolerability", "to", "escitalopram" ]
[ 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01542879
1:14:chronic_disease,15:30:chronic_disease,85:96:treatment
Hemosiderosis/hemochromatosis (patients can still be included in 2nd branch without ferumoxytol)
1
[ "Hemosiderosis/hemochromatosis", "(", "patients", "can", "still", "be", "included", "in", "2nd", "branch", "without", "ferumoxytol", ")" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02004275
18:25:cancer,
Marrow burden of myeloma of at least 30%
1
[ "Marrow", "burden", "of", "myeloma", "of", "at", "least", "30", "%" ]
[ 0, 0, 0, 3, 0, 0, 0, 0, 0 ]
NCT02053792
1:21:chronic_disease
vitamin K deficiency of the newborn
1
[ "vitamin", "K", "deficiency", "of", "the", "newborn" ]
[ 2, 2, 2, 0, 0, 0 ]
NCT01293214
24:34:cancer
High risk of return of malignancy
1
[ "High", "risk", "of", "return", "of", "malignancy" ]
[ 0, 0, 0, 0, 0, 3 ]
NCT02393794
56:65:treatment
who have not fully recovered from side effects of such treatment
1
[ "who", "have", "not", "fully", "recovered", "from", "side", "effects", "of", "such", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01959698
,,142:171:treatment,179:197:treatment,206:219:treatment
Measurable or assessable disease is required; measurable tumor size (at least one node measuring 2.25 cm^2 in bidimensional measurement) per computed tomography (CT) scan, other radiological study, and/or physical exam
1
[ "Measurable", "or", "assessable", "disease", "is", "required", ";", "measurable", "tumor", "size", "(", "at", "least", "one", "node", "measuring", "2.25", "cm^2", "in", "bidimensional", "measurement", ")", "per", "computed", "tomography", "(", "CT", ")", "scan", ",", "other", "radiological", "study", ",", "and/or", "physical", "exam" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 1, 1, 0, 0, 1, 1 ]
NCT02265874
,60:70:treatment,125:143:treatment,145:157:treatment,159:171:treatment,173:184:treatment,
Patients must have been treated with at least 10 mg/day of prednisone or equivalent or one or more immunomodulating agents (hydroxychloroquine, methotrexate, azathioprine, leflunomide) for >3 months before screening
1
[ "Patients", "must", "have", "been", "treated", "with", "at", "least", "10", "mg/day", "of", "prednisone", "or", "equivalent", "or", "one", "or", "more", "immunomodulating", "agents", "(", "hydroxychloroquine", ",", "methotrexate", ",", "azathioprine", ",", "leflunomide", ")", "for", ">", "3", "months", "before", "screening" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02316574
29:38:treatment
Legally mandated to receive treatment
1
[ "Legally", "mandated", "to", "receive", "treatment" ]
[ 0, 0, 0, 0, 1 ]
NCT02578732
13:23:chronic_disease
Preexisting neuropathy is not allowed from any cause
1
[ "Preexisting", "neuropathy", "is", "not", "allowed", "from", "any", "cause" ]
[ 0, 2, 0, 0, 0, 0, 0, 0 ]
NCT02252432
10:21:treatment
Emergent laminectomy
1
[ "Emergent", "laminectomy" ]
[ 0, 1 ]
NCT02501473
18:24:cancer,,48:83:cancer,88:114:cancer
History of other cancer within 2 years (except non-melanoma cutaneous malignancies and cervical carcinoma in situ)
1
[ "History", "of", "other", "cancer", "within", "2", "years", "(", "except", "non-melanoma", "cutaneous", "malignancies", "and", "cervical", "carcinoma", "in", "situ", ")" ]
[ 0, 0, 0, 3, 0, 0, 0, 0, 0, 3, 3, 3, 0, 3, 3, 3, 3, 0 ]
NCT01627301
1:9:chronic_disease
diabetes
1
[ "diabetes" ]
[ 2 ]
NCT02446457
,,,,,,143:152:treatment
Serum total bilirubin =< 1.5 x ULN OR direct bilirubin =< ULN for subjects with total bilirubin levels > 1.5 ULN, performed within 28 days of treatment initiation
1
[ "Serum", "total", "bilirubin", "=", "<", "1.5", "x", "ULN", "OR", "direct", "bilirubin", "=", "<", "ULN", "for", "subjects", "with", "total", "bilirubin", "levels", ">", "1.5", "ULN", ",", "performed", "within", "28", "days", "of", "treatment", "initiation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02159495
22:40:treatment,42:55:treatment,59:68:treatment,
His/her last dose of prior chemotherapy, immunotherapy or radiation is at least 2 weeks out from PBMC collection
1
[ "His/her", "last", "dose", "of", "prior", "chemotherapy", ",", "immunotherapy", "or", "radiation", "is", "at", "least", "2", "weeks", "out", "from", "PBMC", "collection" ]
[ 0, 0, 0, 0, 1, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02964741
34:52:chronic_disease,59:72:chronic_disease,94:101:chronic_disease,105:128:chronic_disease,,
History or current evidence of a psychotic disorder (e.g. schizophrenia) or substance abuse; bipolar or severe major depression, as evidenced by Beck Depression score of ≥ 30
1
[ "History", "or", "current", "evidence", "of", "a", "psychotic", "disorder", "(", "e.g", ".", "schizophrenia", ")", "or", "substance", "abuse", ";", "bipolar", "or", "severe", "major", "depression", ",", "as", "evidenced", "by", "Beck", "Depression", "score", "of", "≥", "30" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 0, 0, 0, 0, 0, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01986075
1:26:chronic_disease
Coronary vascular disease
1
[ "Coronary", "vascular", "disease" ]
[ 2, 2, 2 ]
NCT02271711
9:23:treatment
Chronic corticosteroid dependence
1
[ "Chronic", "corticosteroid", "dependence" ]
[ 0, 1, 0 ]
NCT00909909
1:20:cancer
Medullary carcinoma
1
[ "Medullary", "carcinoma" ]
[ 3, 3 ]
NCT02584647
10:33:chronic_disease,35:61:chronic_disease,,128:146:chronic_disease
unstable coronary artery disease (myocardial infarction (MI) more than 6 months prior to study entry is permitted); or serious cardiac arrhythmia
1
[ "unstable", "coronary", "artery", "disease", "(", "myocardial", "infarction", "(", "MI", ")", "more", "than", "6", "months", "prior", "to", "study", "entry", "is", "permitted", ")", ";", "or", "serious", "cardiac", "arrhythmia" ]
[ 0, 2, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02286687
,36:45:treatment,36:152:treatment,112:120:treatment,122:132:treatment,137:152:treatment,
Patients must be >= 4 weeks beyond treatment with any chemotherapy or other investigational therapy to include hormonal, biological, or targeted agents; or at least 5 half-lives from hormonal, biological, or targeted agents, whichever is shorter at the time of treatment initiation
1
[ "Patients", "must", "be", ">", "=", "4", "weeks", "beyond", "treatment", "with", "any", "chemotherapy", "or", "other", "investigational", "therapy", "to", "include", "hormonal", ",", "biological", ",", "or", "targeted", "agents", ";", "or", "at", "least", "5", "half-lives", "from", "hormonal", ",", "biological", ",", "or", "targeted", "agents", ",", "whichever", "is", "shorter", "at", "the", "time", "of", "treatment", "initiation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02346253
32:45:treatment
Prior allergic reaction to the study drug(s) involved in this protocol
1
[ "Prior", "allergic", "reaction", "to", "the", "study", "drug", "(", "s", ")", "involved", "in", "this", "protocol" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT01626079
70:91:chronic_disease
American College of Cardiology /American Heart Association (ACC/AHA) Stage D heart failure
1
[ "American", "College", "of", "Cardiology", "/American", "Heart", "Association", "(", "ACC/AHA", ")", "Stage", "D", "heart", "failure" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2 ]
NCT01976585
7:17:cancer,
Prior malignancy (active within 5 years of screening)
1
[ "Prior", "malignancy", "(", "active", "within", "5", "years", "of", "screening", ")" ]
[ 0, 3, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02273362
34:38:treatment,181:195:treatment,207:245:chronic_disease,246:272:chronic_disease
individuals who use prescription PPIs and have approval from their primary health care provider to discontinue for the duration of clinical trial participation may be enrolled; an alternate drug to control gastroesophageal reflux disease (GERD)/peptic ulcer disease (PUD) symptoms will be suggested
1
[ "individuals", "who", "use", "prescription", "PPIs", "and", "have", "approval", "from", "their", "primary", "health", "care", "provider", "to", "discontinue", "for", "the", "duration", "of", "clinical", "trial", "participation", "may", "be", "enrolled", ";", "an", "alternate", "drug", "to", "control", "gastroesophageal", "reflux", "disease", "(", "GERD", ")", "/peptic", "ulcer", "disease", "(", "PUD", ")", "symptoms", "will", "be", "suggested" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 2, 2, 2, 2, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT00632853
1:13:treatment
chemotherapy
1
[ "chemotherapy" ]
[ 1 ]
NCT02002260
12:20:treatment,24:36:treatment,70:74:treatment,78:85:treatment
History of ablation or hysterectomy or have any contraindications to COCs or LNG-IUS
1
[ "History", "of", "ablation", "or", "hysterectomy", "or", "have", "any", "contraindications", "to", "COCs", "or", "LNG-IUS" ]
[ 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 1, 0, 1 ]
NCT01676259
5:20:treatment,
All radiology scans must be performed within 28 days prior to registration
1
[ "All", "radiology", "scans", "must", "be", "performed", "within", "28", "days", "prior", "to", "registration" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01620216
,100:109:treatment
Persons of reproductive potential must agree to use an adequate method of contraception throughout treatment
1
[ "Persons", "of", "reproductive", "potential", "must", "agree", "to", "use", "an", "adequate", "method", "of", "contraception", "throughout", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02445768
1:12:chronic_disease,16:32:chronic_disease,48:51:treatment
subcortical or cortical infarct confirmed with MRI
1
[ "subcortical", "or", "cortical", "infarct", "confirmed", "with", "MRI" ]
[ 2, 0, 2, 2, 0, 0, 1 ]
NCT02434809
45:66:treatment
Deemed unable to safely undergo or tolerate flexible bronchoscopy as per institutional guidelines
1
[ "Deemed", "unable", "to", "safely", "undergo", "or", "tolerate", "flexible", "bronchoscopy", "as", "per", "institutional", "guidelines" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT02414607
33:52:allergy_name
Known history of sensitivity to elderberry products
1
[ "Known", "history", "of", "sensitivity", "to", "elderberry", "products" ]
[ 0, 0, 0, 0, 0, 4, 4 ]
NCT02487095
1:4:chronic_disease,38:60:treatment,105:145:treatment,200:217:chronic_disease,236:262:treatment
HIV-positive subjects on combination antiretroviral therapy are ineligible because of the potential for pharmacokinetic interactions with VX-970. In addition, these subjects are at increased risk of lethal infections when treated with marrow-suppressive therapy
1
[ "HIV-positive", "subjects", "on", "combination", "antiretroviral", "therapy", "are", "ineligible", "because", "of", "the", "potential", "for", "pharmacokinetic", "interactions", "with", "VX-970", ".", "In", "addition", ",", "these", "subjects", "are", "at", "increased", "risk", "of", "lethal", "infections", "when", "treated", "with", "marrow-suppressive", "therapy" ]
[ 2, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 1, 1 ]
NCT02565498
9:21:treatment
Planned chemotherapy for (neo)adjuvant treatment
1
[ "Planned", "chemotherapy", "for", "(", "neo", ")", "adjuvant", "treatment" ]
[ 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT02075710
10:13:chronic_disease
positive HIV antibody test or hepatitis serologies
1
[ "positive", "HIV", "antibody", "test", "or", "hepatitis", "serologies" ]
[ 0, 2, 0, 0, 0, 0, 0 ]
NCT02433977
88:101:chronic_disease,103:109:cancer,111:119:chronic_disease
Significant or uncontrolled concomitant medical illness including (but not limited to) heart disease, cancer, diabetes
1
[ "Significant", "or", "uncontrolled", "concomitant", "medical", "illness", "including", "(", "but", "not", "limited", "to", ")", "heart", "disease", ",", "cancer", ",", "diabetes" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 3, 0, 2 ]
NCT03073629
,87:101:chronic_disease
comprehensive echocardiogram within 3 months of index hospital visit showing isolated RV dysfunction
1
[ "comprehensive", "echocardiogram", "within", "3", "months", "of", "index", "hospital", "visit", "showing", "isolated", "RV", "dysfunction" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02401347
54:68:cancer,,102:120:treatment,155:171:cancer
A repeated CT or MRI following the identification of CNS metastases (obtained at least 2 weeks after definitive therapy) must document adequately treated brain metastases
1
[ "A", "repeated", "CT", "or", "MRI", "following", "the", "identification", "of", "CNS", "metastases", "(", "obtained", "at", "least", "2", "weeks", "after", "definitive", "therapy", ")", "must", "document", "adequately", "treated", "brain", "metastases" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 3, 3 ]
NCT02132130
,93:136:treatment
Patients with intact vestibular function in at least one ear (non-study ear) as measured by vestibular evoked myogenic potential (VEMP)
1
[ "Patients", "with", "intact", "vestibular", "function", "in", "at", "least", "one", "ear", "(", "non-study", "ear", ")", "as", "measured", "by", "vestibular", "evoked", "myogenic", "potential", "(", "VEMP", ")" ]
[ 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02562040
24:26:chronic_disease
Primary indication for AT is nocturnal obstructive symptoms (i.e., not recurrent infections or other indications)
1
[ "Primary", "indication", "for", "AT", "is", "nocturnal", "obstructive", "symptoms", "(", "i.e.", ",", "not", "recurrent", "infections", "or", "other", "indications", ")" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03060772
14:36:treatment
Currently on pioglitazone treatment for another reason
1
[ "Currently", "on", "pioglitazone", "treatment", "for", "another", "reason" ]
[ 0, 0, 1, 1, 0, 0, 0 ]
NCT02442102
10:37:treatment
Expected tracheostomy tube placement while in hospital
1
[ "Expected", "tracheostomy", "tube", "placement", "while", "in", "hospital" ]
[ 0, 1, 1, 1, 0, 0, 0 ]
NCT03153410
33:45:treatment,
Must have received last dose of chemotherapy at least 14 days or longer prior to entry into the study
1
[ "Must", "have", "received", "last", "dose", "of", "chemotherapy", "at", "least", "14", "days", "or", "longer", "prior", "to", "entry", "into", "the", "study" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02533674
24:39:chronic_disease,41:62:chronic_disease,64:88:chronic_disease,93:138:chronic_disease,
History or presence of unstable angina, myocardial infarction, congestive heart failure, or clinically significant valvular heart disease within last year
1
[ "History", "or", "presence", "of", "unstable", "angina", ",", "myocardial", "infarction", ",", "congestive", "heart", "failure", ",", "or", "clinically", "significant", "valvular", "heart", "disease", "within", "last", "year" ]
[ 0, 0, 0, 0, 2, 2, 0, 2, 2, 0, 2, 2, 2, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0 ]
NCT00904046
21:33:treatment
Contraindication to pioglitazone use
1
[ "Contraindication", "to", "pioglitazone", "use" ]
[ 0, 0, 1, 0 ]
NCT02132598
,,,,191:200:treatment
The subject has prothrombin time (PT)/ International Normalized Ratio (INR) or partial thromboplastin time (PTT) test ≥ 1.3 x the laboratory ULN within 7 days before the first dose of study treatment
1
[ "The", "subject", "has", "prothrombin", "time", "(", "PT", ")", "/", "International", "Normalized", "Ratio", "(", "INR", ")", "or", "partial", "thromboplastin", "time", "(", "PTT", ")", "test", "≥", "1.3", "x", "the", "laboratory", "ULN", "within", "7", "days", "before", "the", "first", "dose", "of", "study", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT00819208
63:75:treatment
patients who are pre-planned to receive a shorter duration of chemotherapy, including as part of a research study
1
[ "patients", "who", "are", "pre-planned", "to", "receive", "a", "shorter", "duration", "of", "chemotherapy", ",", "including", "as", "part", "of", "a", "research", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01871766
1:17:chronic_disease,
Serum creatinine based on age and gender
1
[ "Serum", "creatinine", "based", "on", "age", "and", "gender" ]
[ 2, 2, 0, 0, 0, 0, 0 ]
NCT02585973
41:51:cancer
Patients with a currently active second malignancy
1
[ "Patients", "with", "a", "currently", "active", "second", "malignancy" ]
[ 0, 0, 0, 0, 0, 0, 3 ]
NCT02304458
51:61:cancer
Patients must have had histologic verification of malignancy at original diagnosis or relapse
1
[ "Patients", "must", "have", "had", "histologic", "verification", "of", "malignancy", "at", "original", "diagnosis", "or", "relapse" ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0 ]
NCT02931110
41:46:cancer,48:50:cancer,52:55:cancer,57:59:cancer,61:64:cancer,65:68:cancer,70:73:cancer,75:77:cancer,82:85:cancer
Part 2 (Cohort Expansion): Diagnosis of DLBCL, FL, MCL, HL, CLL/SLL, ALL, MM, or AML as documented in medical records
1
[ "Part", "2", "(", "Cohort", "Expansion", ")", ":", "Diagnosis", "of", "DLBCL", ",", "FL", ",", "MCL", ",", "HL", ",", "CLL/SLL", ",", "ALL", ",", "MM", ",", "or", "AML", "as", "documented", "in", "medical", "records" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 3, 0, 3, 0, 3, 0, 3, 0, 3, 0, 0, 3, 0, 0, 0, 0, 0 ]
NCT01945814
21:44:chronic_disease
Patients with other uncontrolled infections (see 2.3.2 for definitions)
1
[ "Patients", "with", "other", "uncontrolled", "infections", "(", "see", "2.3.2", "for", "definitions", ")" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02120222
22:61:cancer
Patients with active central nervous system (CNS) malignancy
1
[ "Patients", "with", "active", "central", "nervous", "system", "(", "CNS", ")", "malignancy" ]
[ 0, 0, 0, 3, 3, 3, 3, 3, 0, 0 ]
NCT02901314
27:29:chronic_disease,31:43:chronic_disease,47:82:chronic_disease,84:108:chronic_disease,112:136:chronic_disease
A non-traditional form of HF (hypertrophic or restrictive forms of cardiomyopathy, congenital heart disease or Takotsubo cardiomyopathy)
1
[ "A", "non-traditional", "form", "of", "HF", "(", "hypertrophic", "or", "restrictive", "forms", "of", "cardiomyopathy", ",", "congenital", "heart", "disease", "or", "Takotsubo", "cardiomyopathy", ")" ]
[ 0, 0, 0, 0, 2, 0, 2, 0, 2, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0 ]
NCT02763228
,90:105:treatment,107:119:treatment,123:140:treatment,172:188:treatment,193:209:treatment
Patients who have completed treatment but are within five years of treatment completion (primary surgery, chemotherapy or radiation therapy), whichever was received last. Hormonal therapy and targeted therapy are allowed
1
[ "Patients", "who", "have", "completed", "treatment", "but", "are", "within", "five", "years", "of", "treatment", "completion", "(", "primary", "surgery", ",", "chemotherapy", "or", "radiation", "therapy", ")", ",", "whichever", "was", "received", "last", ".", "Hormonal", "therapy", "and", "targeted", "therapy", "are", "allowed" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0 ]
NCT01312857
23:38:treatment,39:55:treatment,102:111:treatment
Patients who have had prior anti EGFR antibody therapy inhibitors and who have not responded to this treatment will be excluded
1
[ "Patients", "who", "have", "had", "prior", "anti", "EGFR", "antibody", "therapy", "inhibitors", "and", "who", "have", "not", "responded", "to", "this", "treatment", "will", "be", "excluded" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02536846
22:40:chronic_disease
Without history of a psychotic disorder among parents, siblings, or children
1
[ "Without", "history", "of", "a", "psychotic", "disorder", "among", "parents", ",", "siblings", ",", "or", "children" ]
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02355912
1:7:chronic_disease
stroke
2
[ "stroke" ]
[ 2 ]
NCT00801489
20:43:treatment,26:43:treatment,222:244:treatment
Up to one cycle of prior induction therapy will be permitted to include patients in whom presence of good-risk cytogenetics was initially missed; if the patient is in remission from induction therapy, he/she will receive post-remission therapy; if the patient is not in remission then he/she will receive induction therapy
2
[ "Up", "to", "one", "cycle", "of", "prior", "induction", "therapy", "will", "be", "permitted", "to", "include", "patients", "in", "whom", "presence", "of", "good-risk", "cytogenetics", "was", "initially", "missed", ";", "if", "the", "patient", "is", "in", "remission", "from", "induction", "therapy", ",", "he/she", "will", "receive", "post-remission", "therapy", ";", "if", "the", "patient", "is", "not", "in", "remission", "then", "he/she", "will", "receive", "induction", "therapy" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02560623
33:53:treatment
Undergoing clinically indicated diagnostic endoscopy
2
[ "Undergoing", "clinically", "indicated", "diagnostic", "endoscopy" ]
[ 0, 0, 0, 1, 1 ]
NCT02719327
1:9:chronic_disease
Dementia
2
[ "Dementia" ]
[ 2 ]
NCT02421380
15:28:chronic_disease
patients with brain lesions
2
[ "patients", "with", "brain", "lesions" ]
[ 0, 0, 2, 2 ]
NCT02347891
15:39:treatment
Have received treatment with Belimumab at any time prior to Screening
2
[ "Have", "received", "treatment", "with", "Belimumab", "at", "any", "time", "prior", "to", "Screening" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02174549
1:22:treatment,31:49:treatment,51:74:treatment,79:96:treatment,120:125:cancer,146:161:treatment,204:207:treatment,213:226:treatment,
Prior local therapies such as surgical resection, radiofrequency ablation, or alcohol injection are allowed as long as tumor progresses from the prior treatment and the patients are still candidates for TAE. All prior therapy must be at least 4 weeks prior to enrollment and free from treatment-related toxicity
2
[ "Prior", "local", "therapies", "such", "as", "surgical", "resection", ",", "radiofrequency", "ablation", ",", "or", "alcohol", "injection", "are", "allowed", "as", "long", "as", "tumor", "progresses", "from", "the", "prior", "treatment", "and", "the", "patients", "are", "still", "candidates", "for", "TAE", ".", "All", "prior", "therapy", "must", "be", "at", "least", "4", "weeks", "prior", "to", "enrollment", "and", "free", "from", "treatment-related", "toxicity" ]
[ 1, 1, 1, 0, 0, 1, 1, 0, 1, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 3, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02562755
12:25:chronic_disease
History of severe eczema (as determined by the Investigator) requiring medical treatment
2
[ "History", "of", "severe", "eczema", "(", "as", "determined", "by", "the", "Investigator", ")", "requiring", "medical", "treatment" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01373099
49:70:treatment
Infection of a revision as opposed to a primary total hip arthroplast
2
[ "Infection", "of", "a", "revision", "as", "opposed", "to", "a", "primary", "total", "hip", "arthroplast" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02465541
10:35:cancer
No prior type I endometrial cancer diagnosis
2
[ "No", "prior", "type", "I", "endometrial", "cancer", "diagnosis" ]
[ 0, 0, 3, 3, 3, 3, 0 ]
NCT00716066
1:30:chronic_disease
Active uncontrolled infection
2
[ "Active", "uncontrolled", "infection" ]
[ 2, 2, 2 ]
NCT02466750
18:31:chronic_disease
Have a confirmed HIV infection (antibody positivity)
2
[ "Have", "a", "confirmed", "HIV", "infection", "(", "antibody", "positivity", ")" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0 ]
NCT02578641
18:29:chronic_disease
Known history of hepatitis C
2
[ "Known", "history", "of", "hepatitis", "C" ]
[ 0, 0, 0, 2, 2 ]
NCT02771626
25:43:treatment,56:71:treatment,,87:97:treatment,119:157:treatment,
Any condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalent) or other systemic immunosuppressive medications within 2 weeks
2
[ "Any", "condition", "requiring", "systemic", "treatment", "with", "either", "corticosteroids", "(", ">", "10", "mg", "daily", "prednisone", "equivalent", ")", "or", "other", "systemic", "immunosuppressive", "medications", "within", "2", "weeks" ]
[ 0, 0, 0, 1, 1, 1, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02264678
22:45:treatment
Contra-indicated for treatment with olaparib
2
[ "Contra-indicated", "for", "treatment", "with", "olaparib" ]
[ 0, 0, 1, 1, 1 ]
NCT01245712
1:31:cancer,107:116:treatment,120:137:treatment,146:154:treatment
Suspicious microcalcifications, or densities (in the ipsilateral or contralateral breast as documented on mammogram or breast ultrasound) unless biopsied and found to be benign
2
[ "Suspicious", "microcalcifications", ",", "or", "densities", "(", "in", "the", "ipsilateral", "or", "contralateral", "breast", "as", "documented", "on", "mammogram", "or", "breast", "ultrasound", ")", "unless", "biopsied", "and", "found", "to", "be", "benign" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02089607
46:66:chronic_disease
Presence of concomitant thoracoabdominal and aortic arch aneurysm meeting one of the above-mentioned criteria
2
[ "Presence", "of", "concomitant", "thoracoabdominal", "and", "aortic", "arch", "aneurysm", "meeting", "one", "of", "the", "above-mentioned", "criteria" ]
[ 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02389517
84:87:cancer
available deoxyribonucleic acid (DNA) sample will be used for calibration step for MRD evaluation by gene sequencing
2
[ "available", "deoxyribonucleic", "acid", "(", "DNA", ")", "sample", "will", "be", "used", "for", "calibration", "step", "for", "MRD", "evaluation", "by", "gene", "sequencing" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0 ]
NCT01676259
1:18:chronic_disease
hepatitis C virus
2
[ "hepatitis", "C", "virus" ]
[ 2, 2, 2 ]
NCT02857218
45:72:cancer
Pathologically confirmed, locally advanced, malignancy of the esophagus
2
[ "Pathologically", "confirmed", ",", "locally", "advanced", ",", "malignancy", "of", "the", "esophagus" ]
[ 0, 0, 0, 0, 0, 0, 3, 3, 3, 3 ]
NCT02177695
1:22:chronic_disease,
Peripheral neuropathy >/= Grade 2
2
[ "Peripheral", "neuropathy", ">", "/=", "Grade", "2" ]
[ 2, 2, 0, 0, 0, 0 ]
NCT02143830
1:31:cancer
Myelodysplastic Syndrome (MDS)
2
[ "Myelodysplastic", "Syndrome", "(", "MDS", ")" ]
[ 3, 3, 3, 0, 0 ]